These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15347088)

  • 1. [Delaying degeneration or promoting regeneration. 2 successful strategies in osteoporosis].
    MMW Fortschr Med; 2004 Mar; 146(10):46. PubMed ID: 15347088
    [No Abstract]   [Full Text] [Related]  

  • 2. Latest innovation in the treatment of osteoporosis: SERMs and the role of parathyroid hormone.
    Thiebaud D
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S124-5. PubMed ID: 21213508
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
    MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density.
    Riggs BL; Melton LJ
    J Bone Miner Res; 2002 Jan; 17(1):11-4. PubMed ID: 11771656
    [No Abstract]   [Full Text] [Related]  

  • 5. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
    MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
    [No Abstract]   [Full Text] [Related]  

  • 6. [Raloxifene hydrochloride].
    Itabashi A
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():528-35. PubMed ID: 15035185
    [No Abstract]   [Full Text] [Related]  

  • 7. Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?
    Hathirat S; Evans MF
    Can Fam Physician; 2001 Oct; 47():1982-4. PubMed ID: 11723592
    [No Abstract]   [Full Text] [Related]  

  • 8. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?
    Sambrook P
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
    Ohta H
    Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene remains an option.
    MacIver DW
    Can Fam Physician; 2002 Apr; 48():679; author reply 679-80. PubMed ID: 12046354
    [No Abstract]   [Full Text] [Related]  

  • 11. Fewer fractures with raloxifene.
    Feinberg AW
    Health News; 1999 Oct; 5(12):3. PubMed ID: 10536528
    [No Abstract]   [Full Text] [Related]  

  • 12. [SERM for early osteoporosis therapy. Risk for first spinal fracture reduced to half].
    MMW Fortschr Med; 2003 May; 145(22):57. PubMed ID: 12866287
    [No Abstract]   [Full Text] [Related]  

  • 13. Another selective estrogen-receptor modulator for osteoporosis.
    Becker C
    N Engl J Med; 2010 Feb; 362(8):752-4. PubMed ID: 20181977
    [No Abstract]   [Full Text] [Related]  

  • 14. Raloxifene therapy in the reduction of fractures.
    Cefalu CA
    Am Fam Physician; 2000 Mar; 61(5):1272, 1275, 1279-80. PubMed ID: 10735336
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of raloxifene on bone loss and fracture risk in the menopausal woman].
    Vignot E; Meunier PJ
    Contracept Fertil Sex; 1999 Dec; 27(12):858-60. PubMed ID: 10676043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MORE study(raloxifene)].
    Itabashi A
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():442-9. PubMed ID: 15035168
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of vertebral fracture risk with raloxifene.
    Bashore R
    J Fam Pract; 1999 Nov; 48(11):911-2. PubMed ID: 10907630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evidence of raloxifene on postmenopausal osteoporosis].
    Okano H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():374-80. PubMed ID: 18161135
    [No Abstract]   [Full Text] [Related]  

  • 19. Raloxifene. Not better than estrogen.
    Can Fam Physician; 2000 Aug; 46():1592-6, 1599-603. PubMed ID: 10955178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of SERMs on bone health. Efficacy of SERM for incidence of fractures in osteoporotic patients with lifestyle-related diseases].
    Sakai A; Nakamura T
    Clin Calcium; 2010 Mar; 20(3):322-9. PubMed ID: 20190361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.